Kevin E. Bove, MD
Kevin E. Bove, MD, is currently focused on pathogenesis of biliary atresia and other cholestatic disorders of infancy, with long term research interests in the early stages of childhood neoplasia and childhood diseases of skeletal muscle and heart.
Margaret H. Collins, MD
Margaret H. Collins, MD, is a pediatric pathologist specializing in pediatric gastrointestinal pathology, especially eosinophilic gastrointestinal diseases. She has provided biopsy analyses, including primary study endpoints, for several clinical trials testing novel therapies to treat eosinophilic esophagitis in children. She also performs clinical research in other disorders of bowel immunity, and bowel motility disorders.
Anita Gupta, MD
Staff Pathologist, Division of Pathology
Anita Gupta, MD, is a career academic pediatric pathologist at who functions as a surgical pathologist and electron microscopist. Current research focuses on liver tumors, cardiac transplants, vascular anomalies, and cilia abnormalities.
Joel E. Mortensen, PhD
Director, Diagnostic Infectious Diseases Testing Laboratory (Microbiology and Virology)
Joel E. Mortensen, PhD, currently focuses is antimicrobial susceptibility testing of fastidious pediatric pathogens.
Shiva K. Shanmukhappa, DVM, PhD, Diplomate ACVP
Shiva K. Shanmukhappa, DVM, PhD, Diplomate ACVP, is an assistant professor for the UC Department of Pathology and Laboratory Medicine with board certification in comparative veterinary anatomic pathology. He provides pathology support to investigators and also is core pathologist for the Digestive Health Center. His primary research interests have been in studying molecular mechanisms involved in liver repair and regeneration, NASH and metabolic complications in HIV. Additional research interests include virus host interaction, tumor development, neurodegenerative diseases and aging.
Keith F. Stringer, MD
Pathologist, Division of Pathology and Laboratory Medicine
Keith F. Stringer, MD, focuses on the application of the techniques of modern morphology in assessing diseased tissues. His work with these techniques, such as immunofluorescence microscopy and in situ hybridization, have contributed to dozens of publications elucidating features of the pathogenesis of allergic, neoplastic, developmental, and other disease processes.
Peter H. Tang, PhD
Director, Special Chemistry
Peter H. Tang, PhD, focuses on the diagnosis of mitochondrial dysfunction, metabolic disorder, neurodegenerative disease, hemoglobin disorder, neurogenesis, and therapeutic drug monitoring. He has long term research interests in inventing novel approaches for clinical diagnosis by using HPLC and LC/MS.
Kathryn A. Wikenheiser-Brokamp, MD, PhD
Director, Residency Research Program
Kathryn A. Wikenheiser-Brokamp, MD, PhD, investigates pediatric and adult lung diseases, including cancer, which are characterized by aberrant epithelial cell growth and differentiation. A major focus is the molecular mechanisms underlying Rb/p16, p53, and Dicer1 pathway function in lung development and the pathogenesis of lung disease. The ultimate goal is to identify new diagnostic, prognostic and therapeutic targets for common pulmonary disorders.